<DOC>
	<DOCNO>NCT00543010</DOCNO>
	<brief_summary>A study evaluate cardiac metabolic effect MK0767 patient Type 2 Diabetes . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>MK0767 Glipizide Comparator Cardiac Safety Study ( 0767-018 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>You take least one medication high blood sugar Age 21 80 History Type 1 Diabetes Mellitus Currently estrogen replacement therapy regimen Currently weight loss program ongoing weight loss take medication weight loss Having surgery 30 day start study Have take investigational drug past 90 day Have Hepatitis B C Active liver gallbladder disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>